Source: TechCrunch
Summary
Steve Jobs’s venture firm, Yosemite, has grown to a team of 17 in three years. The biotech industry is facing a patent cliff, with several blockbuster drugs losing protection around the same time. Yosemite is now heavily involved in AI, which Jobs says is a huge part of the company’s work.
Our Reading
The launch follows a familiar script.
Yosemite’s growth is attributed to the biotech industry’s patent cliff and the increasing importance of AI. Jobs’s firm is now focused on developing new opportunities in the space. The use of AI is seen as a key factor in Yosemite’s success. This is not the first time AI has been hailed as a game-changer.
Biotech’s Patent Cliff
The biotech industry is facing a patent cliff, with several blockbuster drugs losing protection around the same time. This creates new opportunities for firms like Yosemite.
AI’s Growing Importance
AI has become a huge part of Yosemite’s work, according to Jobs. This is not surprising, given the increasing importance of AI in the tech industry.
Yosemite’s Growth
Yosemite has grown to a team of 17 in three years. This growth is attributed to the firm’s focus on biotech and AI.
The Usual Suspects
Jobs’s enthusiasm for AI is reminiscent of past tech trends. It remains to be seen whether AI will live up to the hype.
Familiar Territory
Yosemite’s story sounds like a familiar tale of tech innovation: a new company, a new technology, and a new market to disrupt. We’ve seen this script before.
Author: Evan Null
